Table 3.

Odds ratios (95% confidence intervals) for serum uPAR in prediction of unfavorable course of AP.

Dependent Variable	uPAR on Admission, per 1 ng/mL	Maximum uPAR, per 1 ng/mL
SAP (2012 Atlanta)	1.41 (0.92–2.17); p = 0.1	1.49 (0.94–2.37); p = 0.08
MSAP plus SAP (2012 Atlanta)	1.16 (0.84–1.60); p = 0.4	1.16 (0.86–1.58); p = 0.3
Persistent (≥48 h) SIRS	0.92 (0.69–1.22); p = 0.5	0.90 (0.69–1.18); p = 0.4
Ranson ≥ 3 points at 48 h	1.39 (1.01–1.89); p = 0.038	1.28 (0.96–1.71); p = 0.08
Organ failure (MMSS ≥ 2 points)	2.14 (1.33–3.46); p = 0.002	2.06 (1.30–3.26); p = 0.002
Cardiovascular failure	2.33 (1.34–4.08); p = 0.002	2.41 (1.29–4.50); p = 0.005
ARDS	1.01 (0.59–1.72); p = 0.9	1.19 (0.73–1.94); p = 0.5
AKI	1.78 (1.11–2.84); p = 0.015	1.77 (1.10–2.85); p = 0.017
ICU transfer	2.06 (1.24–3.43); p = 0.005	2.35 (1.27–4.35); p = 0.005
Death	1.82 (1.06–3.12); p = 0.027	2.25 (1.15–4.37); p = 0.015

AKI, acute kidney injury; ARDS, acute respiratory distress syndrome; ICU, intensive care unit; MMSS, modified Marshall scoring system; MSAP, moderately severe acute pancreatitis; SAP, severe acute pancreatitis; SIRS, systemic inflammatory response syndrome; uPAR, urokinase-type plasminogen activator receptor.